Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Curi Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Curi Bio

Curi Bio

Series A

Curi Bio: Accelerating next-gen medicine discovery through human cells, systems, and data integration.

HQ
Seattle, WA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Curi Bio was founded with the mission to accelerate the discovery of next-generation medicines by integrating human cells, systems, and data. The company focuses on providing advanced 3D tissue models of disease, biosystems for clinically relevant functional analyses, and AI/ML-enabled insights to inform R&D decision-making. Their integrated platform aims to enhance drug safety, efficacy, and potency assessments, catering primarily to the pharmaceutical and biotechnology sectors.

Notable affiliates and investors in Curi Bio include prominent figures and organizations within the biotech industry, although specific names are not provided. Key achievements include the development of their innovative 3D tissue models and biosystems that have significantly impacted drug discovery processes. Overall, Curi Bio's contributions are pivotal in advancing precision medicine by offering more accurate and human-relevant data for therapeutic development.

Curi Bio - Similar Companies

Curie.Bio logo

Curie.Bio

curie.bio

CuriMeta logo

CuriMeta

curimeta.com

Nano Cures logo

Nano Cures

nanocures.com

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

DeepCure logo

DeepCure

deepcure.ai

Insitro logo

Insitro

insitro.com

Manifold Bio logo

Manifold Bio

manifold.bio

OneThree Biotech logo

OneThree Biotech

onethree.bio

Culmination Bio logo

Culmination Bio

culmination.com

Cellaria logo

Cellaria

cellariabio.com

Aureka Biotechnologies logo

Aureka Biotechnologies

aurekabio.com

Cairn Biosciences logo

Cairn Biosciences

cairnbio.com

BioAI Health logo

BioAI Health

bioaihealth.com

Viscient Bio logo

Viscient Bio

CuraFi logo

CuraFi

curafi.com

Curi Bio - Quick Facts

Who are Curi Bio's competitors?

Companies similar to Curi Bio include Curie.Bio, CuriMeta, Nano Cures and CuraSen Therapeutics.

When was Curi Bio founded?

Curi Bio was founded in 2015.

Where is Curi Bio's headquarters located?

Curi Bio's headquarters is located in Seattle, WA, US.

When was Curi Bio's last funding round?

Curi Bio's most recent funding round was for $4.4M (USD) in August 2023.

How much has Curi Bio raised to-date?

As of Aug 23, 2023, Curi Bio has raised a total of $20.4M (USD).

How many employees does Curi Bio have?

Curi Bio has 45 employees as of Feb 4, 2024.

Curi Bio - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotech
  • Drug Discovery
Tags
  • Consulting
  • Platform
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research